Milestone Pharmaceuticals Inc. (MIST) vs Neumora Therapeutics, Inc. Common Stock (NMRA)

A side-by-side comparison of Milestone Pharmaceuticals Inc. and Neumora Therapeutics, Inc. Common Stock across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare
Milestone Pharmaceuticals Inc. logo
MIST
Milestone Pharmaceuticals Inc.
$98M
$0.78HealthcareDelayed quote: Oct 6, 2026, 2:19 PM EDT
Neumora Therapeutics, Inc. Common Stock logo
NMRA
Neumora Therapeutics, Inc. Common Stock
$89M
$0.48HealthcareDelayed quote: Oct 6, 2026, 2:15 PM EDT

Total return — MIST vs NMRA

growth of $100 · dividends reinvested · last 3y
MIST -75.3% (-37.2%/yr)NMRA -96.8% (-68.1%/yr)MIST compounded faster over this window
Log scale — wide-divergence pair
1101001kStart $100202420252026$25$3
MIST NMRA

MIST vs NMRA: by the numbers

  • •MIST is the larger company ($98M vs $89M market cap).
  • •Both run net losses; NMRA's is the smaller (0.00% vs -3585.62% net margin).

Metrics side by side

Valuation

MetricMISTNMRA
P/S ratio41.63N/A
P/B ratio5.352.00

Profitability

MetricMISTNMRA
Gross margin94.58%0.00%
Operating margin-4041.72%0.00%
Net margin-3585.62%0.00%
ROE-461.14%-477.87%
ROIC-49.27%-216.05%

Growth (annualized)

MetricMISTNMRA
Revenue CAGR (5Y)-31.02%N/A
Total return CAGR (5Y)-33.18%N/A

Go deeper

Full MIST analysisFull NMRA analysisInteractive comparison tool

Dig into the metrics

Milestone Pharmaceuticals ROENeumora Therapeutics, Inc. Common Stock ROEMilestone Pharmaceuticals operating marginNeumora Therapeutics, Inc. Common Stock operating marginMilestone Pharmaceuticals revenue growthNeumora Therapeutics, Inc. Common Stock revenue growthMilestone Pharmaceuticals free cash flowNeumora Therapeutics, Inc. Common Stock free cash flow

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.